Skip to content

US · QLGN · BIOTECHNOLOGY

Qualigen Therapeutics, Inc. (QLGN) intrinsic value and stock valuation

$2.37as of 2025-12-15 · Mkt cap 4.45M

Data updated · price as of 2025-12-15

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Qualigen Therapeutics, Inc. DCF and intrinsic value

InvestorsCraft values QLGN with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from QLGN’s statements →

Healthcare · Biotechnology Carlsbad, CA 92011 qlgntx.com

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

About Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

CEO
Kevin A. Richardson II
Employees
4
Beta
0.28

Explore

Frequently asked questions

What is the intrinsic value of Qualigen Therapeutics, Inc. (QLGN)?

InvestorsCraft does not currently publish an intrinsic value for QLGN. How the IC value is calculated.

Is QLGN undervalued?

InvestorsCraft does not publish an undervaluation signal for QLGN at this time.

How is the intrinsic value calculated?

InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

How often is this page updated?

Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Aug 12, 2026.

Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.